id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-352991-duqkpkll	Waghmare, Alpana	Respiratory Syncytial Virus Lower Respiratory Disease in Hematopoietic Cell Transplant Recipients: Viral RNA Detection in Blood, Antiviral Treatment, and Clinical Outcomes	2013-09-24		.txt	text/plain	5112	245	43	Although RSV RNA has been detected in serum from patients with RSV lower respiratory disease (LRD) after HCT, the association with clinical outcomes has not been well established in multivariable models. Univariate analysis at day 90 following RSV LRD revealed several factors that were statistically significantly associated with overall mortality and pulmonary death including transplant year, cell source, conditioning regimen, WBC count, monocyte count, platelet count, oxygen requirement at diagnosis, steroid use at diagnosis, palivizumab treatment, and ribavirin treatment following LRD (Supplementary Table 1 ). Hazard ratios and 95% confidence intervals from multivariable models evaluating respiratory syncytial virus (RSV) RNA detection in blood as a risk factor for overall mortality and pulmonary death by day 90 following RSV lower respiratory disease (LRD; n = 92), including P values.	./cache/cord-352991-duqkpkll.txt	./txt/cord-352991-duqkpkll.txt